EPO grants Sonnet EU Patent No. EP3583125 B1 for Fully Human Albumin Binding (FHAB®) domain fusion proteins, expanding global IP protection. Sonnet BioTherapeutics Holdings, Inc. announced that the ...
After blood vessel damage, effective blood clotting is essential to halt bleeding. However, this process is inefficient in some individuals due to hereditary factors. Hemophilia B, for example, ...
PRINCETON, NJ, Dec. 04, 2024 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (SONN), a clinical-stage company developing innovative targeted immunotherapeutic drugs, today announced the ...
Scientists at the Institute of Molecular Biology and Biotechnology (IMBB-FORTH) and the University of Crete, together with collaborators from Greece, Europe, the U.S., and India, have discovered a ...
In the quest to advance therapeutic development, the creation of transgenic mouse models expressing human proteins has become increasingly prevalent. These models have a unique ability to address gaps ...
Skoltech researchers and their colleagues have synthesized and tested protein-polymer microbubbles for use in medical ultrasound imaging of internal organs. Administered intravenously, the ...
Albumin is the most common protein in the blood, a vital molecule produced by the liver that helps maintain fluid balance and transports proteins and hormones. It also plays a key role in fighting off ...
News-Medical.Net on MSN
Blood protein albumin identified as key defense against deadly black fungus
A new international study published in Nature has identified albumin, the most abundant protein in human blood, as a powerful ...
Researchers from Aarhus University and the Italian Institute of Technology have discovered how certain proteins can attach to special structures in RNA, called G-quadruplexes. Additionally, they have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results